Put companies on watchlist
iRhythm Technologies
ISIN: US4500561067
WKN: A2ATTS
More AI Integrations
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

iRhythm Technologies · ISIN: US4500561067 · PR Newswire (ID: 20250617DC12010)
17 June 2025 05:00PM

iRhythm Technologies, Inc. (NASDAQ: IRTC) Investor Alert: Schubert Jonckheer & Kolbe LLP Investigating Possible Shareholder Claims for False Statements and Insider Trading


SAN FRANCISCO, June 17, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises iRhythm Technologies, Inc. investors that the firm is investigating potential legal claims relating to alleged false statements exaggerating the capabilities of iRhythm's wearable Zio AT heart event monitor. Current shareholders are encouraged to contact the firm.

On June 3, 2025, Judge Jacqueline Scott Corley of the U.S. District Court for the Northern District of California issued an order allowing key claims in a securities fraud lawsuit against iRhythm and CEO Quentin Blackford to move forward. The lawsuit alleges that between November 2021 and August 2024, iRhythm intentionally misled investors by overstating the accuracy and reliability of its Zio AT monitor and misrepresented its suitability for high-risk patients—causing its stock to trade at inflated prices. Judge Corley found that the complaint sufficiently alleged that the defendants made false and misleading statements with an intent to defraud. During this time, company insiders sold approximately $18 million worth of iRhythm stock. The U.S. Department of Justice is also investigating iRhythm's marketing practices. As the truth came out in a series of disclosures from November 2022 through August 2024, iRhythm's stock price fell significantly.

We are investigating potential wrongdoing by iRhythm's directors and officers in connection with these allegations.

If you own stock in iRhythm, you may have legal options. Please contact us today at https://www.classactionlawyers.com/irhythm to learn more.

About Schubert Jonckheer & Kolbe LLP

Schubert Jonckheer & Kolbe represents shareholders, employees, and consumers in class actions against corporate defendants, as well as shareholders in derivative actions against officers and directors. The firm is based in San Francisco and, with the help of co-counsel, litigates cases nationwide.

Contact

Dustin L. Schubert

Schubert Jonckheer & Kolbe LLP

dschubert@schubertlawfirm.com

Tel: 415-788-4220

Cision View original content:https://www.prnewswire.com/news-releases/irhythm-technologies-inc-nasdaq-irtc-investor-alert-schubert-jonckheer--kolbe-llp-investigating-possible-shareholder-claims-for-false-statements-and-insider-trading-302483385.html

SOURCE Schubert Jonckheer & Kolbe LLP

Visual performance / price development - iRhythm Technologies
Smart analysis and research tools can be found here.
MIC: XNAS
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2025
PR Newswire
Contact:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942